Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Antibiot (Tokyo) ; 70(2): 122-129, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27381521

RESUMEN

Enterobacter cloacae is a Gram-negative bacterium associated with high morbidity and mortality in intensive care patients due to its resistance to multiple antibiotics. Currently, therapy against multi-resistant bacteria consists of using colistin, in spite of its toxic effects at higher concentrations. In this context, colistin-resistant E. cloacae strains were challenged with lower levels of colistin combined with other antibiotics to reduce colistin-associated side effects. Colistin-resistant E. cloacae (ATCC 49141) strains were generated by serial propagation in subinhibitory colistin concentrations. After this, three colistin-resistant and three nonresistant replicates were isolated. The identity of all the strains was confirmed by MALDI-TOF MS, VITEK 2 and MicroScan analysis. Furthermore, cross-resistance to other antibiotics was checked by disk diffusion and automated systems. The synergistic effects of the combined use of colistin and chloramphenicol were observed via the broth microdilution checkerboard method. First, data here reported showed that all strains presented intrinsic resistance to penicillin, cephalosporin (except fourth generation), monobactam, and some associations of penicillin and ß-lactamase inhibitors. Moreover, a chloramphenicol and colistin combination was capable of inhibiting the induced colistin-resistant strains as well as two colistin-resistant clinical strains. Furthermore, no cytotoxic effect was observed by using such concentrations. In summary, the data reported here showed for the first time the possible therapeutic use of colistin-chloramphenicol for infections caused by colistin-resistant E. cloacae.


Asunto(s)
Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Colistina/farmacología , Farmacorresistencia Bacteriana Múltiple , Enterobacter cloacae/efectos de los fármacos , Pared Celular/efectos de los fármacos , ADN Bacteriano , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , ARN Bacteriano
2.
Curr Microbiol ; 72(5): 538-44, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26769111

RESUMEN

Over the last few years, a growing number of proteinase inhibitors have been isolated from plants and particularly from seeds and have shown antimicrobial activity. A 20,000 Da serine peptidase inhibitor, named ILTI, was isolated from Inga laurina seeds and showed potent inhibitory enzymatic activity against trypsin. The aim of this study was to determine the effects of ILTI on the growth of pathogenic and non-pathogenic microorganisms. We observed that ILTI strongly inhibited in particular the growth of Candida tropicalis and Candida buinensis, inducing cellular agglomeration. However, it was ineffective against human pathogenic bacteria. We also investigated the potential of ILTI to permeabilize the plasma membrane of yeast cells. C. tropicalis and C. buinensis were incubated for 24 h with the ILTI at different concentrations, which showed that this inhibitor induced changes in the membranes of yeast cells, leading to their permeabilization. Interestingly, ILTI induced the production of reactive oxygen species (ROS) in C. tropicalis and C. buinensis cells. Finally, ILTI was coupled with fluorescein isothiocyanate, and subsequent treatment of C. tropicalis and C. buinensis with DAPI revealed the presence of the labeled protein in the intracellular spaces. In conclusion, our results indicated the ability of peptidase inhibitors to induce microbial inhibition; therefore, they might offer templates for the design of new antifungal agents.


Asunto(s)
Antifúngicos/farmacología , Fabaceae/química , Proteínas de Plantas/farmacología , Inhibidores de Tripsina/farmacología , Candida/efectos de los fármacos , Candida/metabolismo , Candidiasis/microbiología , Humanos , Pruebas de Sensibilidad Microbiana , Estrés Oxidativo/efectos de los fármacos , Semillas/química
3.
Antimicrob Agents Chemother ; 56(4): 1714-24, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22290970

RESUMEN

Antimicrobial peptides (AMPs) are effective antibiotic agents commonly found in plants, animals, and microorganisms, and they have been suggested as the future of antimicrobial chemotherapies. It is vital to understand the molecular details that define the mechanism of action of resistance to AMPs for a rational planning of the next antibiotic generation and also to shed some light on the complex AMP mechanism of action. Here, the antibiotic resistance of Escherichia coli ATCC 8739 to magainin I was evaluated in the cytosolic subproteome. Magainin-resistant strains were selected after 10 subsequent spreads at subinhibitory concentrations of magainin I (37.5 mg · liter⁻¹), and their cytosolic proteomes were further compared to those of magainin-susceptible strains through two-dimensional electrophoresis analysis. As a result, 41 differentially expressed proteins were detected by in silico analysis and further identified by tandem mass spectrometry de novo sequencing. Functional categorization indicated an intense metabolic response mainly in energy and nitrogen uptake, stress response, amino acid conversion, and cell wall thickness. Indeed, data reported here show that resistance to cationic antimicrobial peptides possesses a greater molecular complexity than previously supposed, resulting in cell commitment to several metabolic pathways.


Asunto(s)
Antibacterianos/farmacología , Citosol/fisiología , Farmacorresistencia Bacteriana/genética , Escherichia coli/efectos de los fármacos , Magaininas/farmacología , Proteoma/genética , Aminoácidos/metabolismo , Pared Celular/metabolismo , Pared Celular/ultraestructura , Simulación por Computador , Electroforesis en Gel de Poliacrilamida , Metabolismo Energético/genética , Fermentación , Pruebas de Sensibilidad Microbiana , Nitrógeno/metabolismo , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Espectrometría de Masas en Tándem
4.
Curr Microbiol ; 64(5): 501-5, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22367403

RESUMEN

Marine organisms represent approximately half of the world's biodiversity by virtue of the sea being an immense reservoir of bioactive molecules. Here, antimicrobial crude extract activities of different marine invertebrates from the Caribbean Sea were evaluated. One of the most active, crude extracts was that marine snail Cenchritis muricatus, it was capable of totally inhibiting the development of Staphylococcus aureus and also showed a growth inhibition of 95.9% in Escherichia coli. Aiming to isolate molecules that confirm antimicrobial activity, the crude extract was purified by reversed-phase HPLC C-18 chromatography. Thereafter, one of the obtained fractions preserved this antibacterial activity. Furthermore, SDS-PAGE analysis (15%) showed the presence of two proteins of molecular masses with approximately 10 and 15 kDa, respectively. The first 19 amino acids of both proteins were sequenced by using Edman degradation, yielding unidentified primary structures compared against sequences deposited at NCBI databank. This is the first report of antibacterial proteins isolated from the mollusk Cenchritis muricatus and these proteins could be used as antibiotic alternatives in the aquacultural industry, as well as in agricultural or biomedical research.


Asunto(s)
Antibacterianos/farmacología , Escherichia coli/efectos de los fármacos , Moluscos/química , Proteínas/farmacología , Staphylococcus aureus/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Antibacterianos/química , Antibacterianos/metabolismo , Región del Caribe , Evaluación Preclínica de Medicamentos , Escherichia coli/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Moluscos/clasificación , Moluscos/metabolismo , Proteínas/química , Proteínas/metabolismo , Staphylococcus aureus/crecimiento & desarrollo
5.
Protein J ; 30(5): 340-50, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21691771

RESUMEN

Pathogenic bacteria constitute an important cause of hospital-acquired infections. However, the misuse of available bactericidal agents has led to the appearance of antibiotic-resistant strains. Thus, efforts to seek new antimicrobials with different action mechanisms would have an enormous impact. Here, a novel antimicrobial protein (SiAMP2) belonging to the 2S albumin family was isolated from Sesamum indicum kernels and evaluated against several bacteria and fungi. Furthermore, in silico analysis was conducted in order to identify conserved residues through other 2S albumin antimicrobial proteins (2S-AMPs). SiAMP2 specifically inhibited Klebsiella sp. Specific regions in the molecule surface where cationic (RR/RRRK) and hydrophobic (MEYWPR) residues are exposed and conserved were proposed as being involved in antimicrobial activity. This study reinforces the hypothesis that plant storage proteins might also play as pathogen protection providing an insight into the mechanism of action for this novel 2S-AMP and evolutionary relations between antimicrobial activity and 2S albumins.


Asunto(s)
Albuminas 2S de Plantas/química , Albuminas 2S de Plantas/farmacología , Antibacterianos/química , Antibacterianos/farmacología , Sesamum/química , Albuminas 2S de Plantas/aislamiento & purificación , Antibacterianos/aislamiento & purificación , Simulación por Computador , Enterobacteriaceae/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Hongos Mitospóricos/efectos de los fármacos , Filogenia , Semillas/química , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA